2015;125:521 5. S10.2.2-19. Shimada C, Akaishi R, Cho K, et al. Outcomes of 83 fetuses exposed to angiotensin receptor blockers during the sec- ond or third trimesters: a literature review. Hypertens Res. 2015;38:308 13. 10.3. Age-Related Issues 10.3.1. Older Persons S10.3.1-1. Williamson JD, Supiano MA, Applegate WB, et al. Intensive vs standard blood pressure control and cardiovascular disease outcomes in adults aged 75 years: a randomized clinical trial. JAMA. 2016;315:2673 82. S10.3.1-2. Ettinger WH Jr, Fried LP, Harris T, et al. Self-reported causes of physical disability in older people: the Cardiovascular Health Study. CHS Collaborative Research Group. J Am Geriatr Soc. 1994;42:1035 44. S10.3.1-3. Ferrucci L, Guralnik JM, Pahor M, et al. Hospital diagnoses, Medicare charges, and nursing home admissions in the year when older persons become severely disabled. JAMA. 1997;277:728 34. S10.3.1-4. den Ouden MEM, Schuurmans MJ, Mueller-Schotte S, et al. Do subclinical vascular abnormalities precede impaired physical abil- ity and ADL disability? Exp Gerontol. 2014;58:1 7. S10.3.1-5. Ezzati M, Lopez AD, Rodgers A, et al. Selected major risk factors and global and regional burden of disease. Lancet. 2002;360:1347 60. S10.3.1-6. Duprez DA. Systolic hypertension in the elderly: addressing an unmet need. Am J Med. 2008;121:179 84.e3. S10.3.1-7. Egan BM, Li J, Hutchison FN, et al. Hypertension in the United States, 1999 to 2012: progress toward Healthy People 2020 goals. Circulation. 2014;130:1692 9. S10.3.1-8. Liu X, Rodriguez CJ, Wang K. Prevalence and trends of isolated systolic hypertension among untreated adults in the United States. J Am Soc Hypertens. 2015;9:197 205. S10.3.1-9. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group. JAMA. 1991;265:3255 64. S10.3.1-10. Staessen JA, Fagard R, Thijs L, et al. 